×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Artemis Medicare Services Limi | 2567.56 | 214.17 | 2497.99 | 1.35 | 3,265 | 37.4 |
| HIKAL LTD. | 3814.0 | -227.0 | 3804.0 | -1.84 | 3227 | 51.0 |
| SOLARA ACTIVE PHARMA SCIENCES | 3201.3 | 105.2 | 3191.5 | 2.46 | 3010 | 123.0 |
Artemis Medicare Services Limited, with Security Code 542919, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 187.0 | 201.2 | 216.9 | 210.3 | 216.9 | 216.9 | 234.7 | 226.9 | 234.8 | 249.8 |
| Expenses | 162.5 | 173.9 | 183.6 | 178.6 | 180.8 | 181.2 | 192.9 | 190.1 | 199.2 | 208.9 |
| Operating Profit | 24.5 | 27.3 | 33.3 | 31.7 | 36.1 | 35.7 | 41.8 | 36.8 | 35.6 | 40.9 |
| OPM % | 13.11% | 13.55% | 15.36% | 15.08% | 16.65% | 16.45% | 17.81% | 16.23% | 15.15% | 16.36% |
| Other Income | 2.2 | 1.2 | 2.5 | 1.7 | 1.9 | 4.4 | 7.5 | 8.8 | 12.2 | 7.0 |
| Interest | 4.9 | 6.5 | 7.5 | 7.6 | 8.1 | 7.7 | 7.6 | 7.7 | 7.5 | 7.1 |
| Depreciation | 8.3 | 8.6 | 9.4 | 9.6 | 10.5 | 10.2 | 10.6 | 10.9 | 11.2 | 10.7 |
| Profit before tax | 13.6 | 13.4 | 18.9 | 16.3 | 19.4 | 22.1 | 31.1 | 27.0 | 29.0 | 30.1 |
| Tax % | -23.4% | -25.8% | -27.3% | -29.2% | -28.4% | -23.6% | -27.4% | -23.2% | -19.7% | 28.8% |
| Net Profit | 10.4 | 9.9 | 13.8 | 11.5 | 13.9 | 16.9 | 22.6 | 20.8 | 23.2 | 21.4 |
| EPS in Rs | 0.75 | 0.72 | 0.99 | 0.83 | 1 | 1.14 | 1.43 | 1.31 | 0 | 1.35 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 187.5 | 195.3 | 209.5 | 225.0 | 218.8 | 225.2 | 223.2 | 241.4 | 232.4 | 239.9 |
| Expenses | 161.9 | 169.6 | 181.6 | 190.8 | 186.1 | 187.3 | 187.0 | 199.2 | 194.9 | 203.9 |
| Operating Profit | 25.6 | 25.7 | 27.9 | 34.2 | 32.6 | 38.0 | 36.2 | 42.3 | 37.5 | 36.0 |
| OPM % | 13.65% | 13.14% | 13.31% | 15.2% | 14.92% | 16.85% | 16.2% | 17.51% | 16.12% | 15% |
| Other Income | 1.2 | 2.4 | 1.3 | 2.4 | 1.8 | 1.9 | 4.4 | 7.4 | 8.8 | 12.3 |
| Interest | 5.2 | 5.3 | 6.9 | 7.9 | 8.0 | 8.6 | 8.1 | 8.0 | 8.0 | 7.8 |
| Depreciation | 8.4 | 8.7 | 9.2 | 10.0 | 10.2 | 11.0 | 10.8 | 11.2 | 11.5 | 11.7 |
| Profit before tax | 13.3 | 14.0 | 13.1 | 18.8 | 16.3 | 20.2 | 21.6 | 30.6 | 26.8 | 28.7 |
| Tax % | -22.7% | -23.7% | -25.6% | -28% | -29.2% | -29.3% | -23.6% | -27.6% | -23.2% | -19.9% |
| Net Profit | 10.3 | 10.7 | 9.8 | 13.5 | 11.6 | 14.3 | 16.5 | 22.1 | 20.6 | 22.9 |
| EPS in Rs | 0.75 | 0.76 | 0.71 | 0.98 | 0.83 | 1.02 | 1.12 | 1.41 | 1.31 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 19% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 32% |
| 3 Years: | 36% |
| TTM: | 70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 77% |
| 3 Years: | 80% |
| 1 Year: | 38% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 33% |
| 3 Years: | 37% |
| TTM: | 68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 77% |
| 3 Years: | 80% |
| 1 Year: | 38% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|